NLRP3 and neoplasm: DC activation by binding to ATP also promotes caspase-1 dependent NLRP3 inflammasome formation and the release of IL-1β [16], which in turn promotes CD8+ T cells [16] and IL-17 [17] producing-γδ T cell mediated anti-tumor response.